Application of Cost Analysis Methods in Pharmacoeconomic Decisions

By today, in our business environment, mostly based on innovation, the potential opportunities in the pharmaceutical sector and impact of these to the national economic trends has a determining significance. National and international importance of the pharmaceutical industry defined by not only the prominent role of application of the biochemical academic research, but also the humanitarian concerns which increasingly appreciating in the global context. These facts – in view of growing efficient immune substances developing procedures – are stronger pressure on the industrial actors, with this affecting the profitability of future operations. Broader sense pharmacoeconomics includes the examination of the main factors which influence the change of expenditures produced in the health system, furthermore compares the value of different pharmaceutical drugs or drug therapies by using many analytical methods such as cost minimalization analysis, cost benefit analysis, cost effectiveness analysis and the cost utility analysis. Our analysis is mostly theoretical.